The DOI matches its Crossref record.
ZnO‐Functionalized Upconverting Nanotheranostic Agent: Multi‐Modality Imaging‐Guided Chemotherapy with On‐Demand Drug Release Triggered by pH
Abstract
Limited therapeutic efficiency and severe side effects in patients are two major issues existing in current chemotherapy of cancers in clinic. To design a proper theranostic platform seems thus quite needed to target cancer cells accurately by bioimaging and simultaneously release drugs on demand without premature leakage. A novel ZnO‐functionalized upconverting nanotheranostic platform has been fabricated for clear multi‐modality bioimaging (upconversion luminescence (UCL), computed tomography (CT), and magnetic resonance imaging (MRI)) and specific pH‐triggered on‐demand drug release. In our theranostic platform multi‐modality imaging provides much more detailed and exact information for cancer diagnosis than single‐modality imaging. In addition, ZnO can play the role of a “gatekeeper” to efficiently block the drug in the mesopores of the as‐prepared agents until it is dissolved in the acidic environment around tumors to realize sustained release of the drug. More importantly, the biodegradable ZnO, which is non‐toxic against normal tissues, endows the as‐prepared agents with high therapeutic effectiveness but very low side effects. These findings are of great interests and will inspire us much to develop novel effective imaging‐guided on‐demand chemotherapies in cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
ZnO nanostructured materials and their potential applications: progress, challenges and perspectives
Raha, S., & Ahmaruzzaman, M. (2022) · Nanoscale Advances · doi:10.1039/d1na00880c · Cited by 1,107
Zinc oxide nanoparticles: a promising nanomaterial for biomedical applications
Mishra, P. K., Mishra, H., Ekielski, A., Talegaonkar, S., & Vaidya, B. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.08.006 · Cited by 811
Zheng, D.-W., Li, B., Li, C.-X., Fan, J.-X., Lei, Q., Li, C., Xu, Z., & Zhang, X.-Z. (2016) · ACS Nano · doi:10.1021/acsnano.6b04156 · Cited by 663
A Mini Review of Antibacterial Properties of ZnO Nanoparticles
Gudkov, S. V., Burmistrov, D. E., Serov, D. A., Rebezov, M. B., Semenova, A. A., & Lisitsyn, A. B. (2021) · Frontiers in Physics · doi:10.3389/fphy.2021.641481 · Cited by 589
Anjum, S., Hashim, M., Malik, S. A., Khan, M., Lorenzo, J. M., Abbasi, B. H., & Hano, C. (2021) · Cancers · doi:10.3390/cancers13184570 · Cited by 575
Precise nanomedicine for intelligent therapy of cancer
Chen, H., Gu, Z., An, H., Chen, C., Chen, J., Cui, R., Chen, S., Chen, W., Chen, X., Chen, X., et al. (2018) · Science China Chemistry · doi:10.1007/s11426-018-9397-5 · Cited by 409
Multifaceted Design and Emerging Applications of Tissue Adhesives
Ma, Z., Bao, G., & Li, J. (2021) · Advanced Materials · doi:10.1002/adma.202007663 · Cited by 269
Liu, B., Chen, Y., Li, C., He, F., Hou, Z., Huang, S., Zhu, H., Chen, X., & Lin, J. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201501582 · Cited by 262
Singh, T. A., Das, J., & Sil, P. C. (2020) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2020.102317 · Cited by 256
Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: An update
Castillo, R. R., Lozano, D., González, B., Manzano, M., Izquierdo-Barba, I., & Vallet-Regí, M. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1598375 · Cited by 197
Qin, S., Xu, Y., Li, H., Chen, H., & Yuan, Z. (2022) · Biomaterials Science · doi:10.1039/d1bm00317h · Cited by 56
Asadi, N., Gharbavi, M., Rezaeejam, H., Farajollahi, A., & Johari, B. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124285 · Cited by 23
Metadata
- Authors
- Wang, Y., Song, S., Liu, J., Liu, D., & Zhang, H.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2014-11-03
- Volume
- 54
- Issue
- 2
- Pages
- 536-540
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2101376345
- Cited by
- 211
- References
- 0
- FWCI
- 12.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.